Drug resistance modulation in the laboratory and the clinic. - Suppr | 超能文献

Drug resistance modulation in the laboratory and the clinic.

作者信息

Dalton W S

机构信息

University of Arizona Cancer Center, Tucson 85724.

出版信息

Semin Oncol. 1993 Feb;20(1):64-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Drug resistance modulation in the laboratory and the clinic.

Semin Oncol. 1993 Feb;20(1):64-9.

2

[Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].

Lakartidningen. 1991 Dec 18;88(51-52):4441-4.

3

[Resistance, the cause of failure in antineoplastic chemotherapies].[抗药性，抗肿瘤化疗失败的原因]

Pathol Biol (Paris). 1989 Feb;37(2):125-7.

4

Cancer robustness: tumour tactics.癌症的稳健性：肿瘤的策略。

Nature. 2003 Nov 13;426(6963):125. doi: 10.1038/426125a.

5

[Multidrug resistance].

Vopr Onkol. 1991;37(7-8):780-8.

6

Combination chemotherapy--theory and practice.联合化疗——理论与实践

Semin Oncol. 1977 Jun;4(2):227-53.

7

[The mechanisms of the resistance of malignant cells to cytostatics].[恶性细胞对细胞抑制剂的耐药机制]

Dtsch Med Wochenschr. 1991 Feb 1;116(5):186-91. doi: 10.1055/s-2008-1063599.

8

BMS and Exelixis target tumor suppression pathways.

Expert Rev Anticancer Ther. 2001 Aug;1(2):167.

9

[Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].

Vopr Onkol. 1983;29(3):106-13.

10

Introduction to resistance to anticancer agents.抗癌药物耐药性介绍。

Oncogene. 2003 Oct 20;22(47):7262-4. doi: 10.1038/sj.onc.1206932.

引用本文的文献

1

Overcoming drug resistance in ovarian carcinoma.克服卵巢癌的耐药性。

Curr Oncol Rep. 2001 Jan;3(1):19-26. doi: 10.1007/s11912-001-0038-z.

2

Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival.免疫组化证据表明，非小细胞肺癌中的P-糖蛋白与较短生存期相关。

Surg Today. 1999;29(11):1141-7. doi: 10.1007/BF02482262.

3

Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.锝-99m 甲氧基异丁基异腈在显示谷胱甘肽相关耐药性的人乳腺癌细胞系中的摄取。

Eur J Nucl Med. 1996 May;23(5):568-70. doi: 10.1007/BF00833393.